mechanisms operating in the common, sporadic cases. AnticiKeywords: leukemia; familial; anticipation pation occurs in Huntington disease, myotonic dystrophy, and other inherited neurodegenerative illness where it results from the expansion of unstable trinucleotide repeat sequences.
Introduction
Since this remains as the only molecularly defined instrument for anticipation, I weigh the possibility that an analogous situ-A family history of leukemia in a first degree relative increases ation holds for leukemia genes. I also review evidence that the risk for leukemia by approximately three-to five-fold. 1, 2 anticipation may be present in other types of familial cancer, The magnitude of this risk elevation is equivalent to or even including those in which the gene has been characterized and greater than that exhibited for malignancies well known to does not contain trinucleotide repeat tracts, but is involved have a substantial proportion of cases resulting from autosoin maintaining genome integrity. Here I propose a novel and mal dominant inheritance of a mutant tumor suppressor gene, alternative hypothesis for anticipation in familial cancer based such as breast cancer 3 and colorectal carcinoma. 4 On the on the inheritance of a cascade of de novo mutations in secother hand, familial leukemia is exceptionally rare, and only a ondary tumor suppressor genes resulting from a primary defect few pedigrees obviously transmitting leukemia have ever been in a gene responsible for DNA fidelity. recognized. This paradox and other observations suggest that the fraction of leukemia attributable to heritable factors could be markedly under appreciated. First, acute lymphocytic leuLeukemia as part of a syndrome kemia (ALL) is predominately a disease of childhood. 5 In other childhood malignancy, such as retinoblastoma and Wilm's Several syndromic illnesses have leukemia as a component tumor, a large proportion of cases are the result of germline feature (Table 1) . mutations in a tumor suppressor gene. 6 Conceivably, an analogous phenomenon pertains to leukemia. Second, although epidemiological studies have failed to find consistent links Down syndrome between leukemia and environmental exposures (excepting radiation and chemotherapy specific increase in risk for M7 AML among Down syndrome Trisomy 8 syndrome individuals is estimated at up to 400-fold. 21 After the age of 3, acute lymphocytic leukemia (ALL) predominates. 24, 25 IndiAmong hematologic malignancies with a single chromosomal aberration, acquired trisomy 8 is the most common finding viduals mosaic for Down syndrome who develop leukemia 26 or transient leukemoid reactions 27 invariably have leukemic (reviewed in Ref. 34 ). Trisomy 8 is found in up to 25% of myeloid dysplasia and leukemia. As a sole chromosomal involvement of the trisomy 21 clones, confirming that a locus or loci on this chromosome is responsible. Attempts have change, it is most common with M5 monocytic AML, present in about 10% of all cases. Constitutional trisomy 8 is been made to define the critical region for leukemia by comparing atypical Down syndrome karyotypes, such as ring extremely rare, and, presumably owing to the lethality of the multiple attendant congenital abnormalities, exists primarily chromosomes and isochromosomes, [28] [29] [30] and two leukemia genes map to this region on the long arm of chromosome 21. in individuals in the mosaic state. Clinical features of constitutional trisomy 8 mosaicism include a characteristic facial The AML1 locus on 21q22.3 encodes the A subunit of core binding factor (CBFA) and is the site of recurrent and skeletal limb dysmorphism with variable degrees of mental retardation. There are several case reports of trisomy 8 t(8;21)(q22;q22) translocation resulting in a chimeric fusion protein. 31 This translocation is among the most frequent mosaic individuals developing aplastic anemia, myelodysplasia, and acute and chronic myelogenous leukemia, with, in chromosomal abnormalities in AML, especially the M2 subtype. The core binding factor binds to a DNA sequence motif all cases, the malignant clone being derived from the trisomy 8 population of cells. Potential chromosome 8 genes responcommon to many genes expressed in hematopoietic cells and is a homologue of the Drosophila runt segmentation gene.
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sible for this association may be suggested by the translocation breakpoints found in sporadic leukemia. The reciprocal gene Knockout mouse experiments demonstrate that CBFA is required for embryonic hematopoiesis. 32 The second gene is fusion partner for t(8;21)(q22;q22) with CBFA is ETO on chromosome 8, a gene of uninvestigated function expressed during defined by a large family inheriting autosomal dominant platelet granule defects and predisposition to AML, for which linkhematopoiesis. 31 Recurrent translocations involving 8p11 occur in some AML and are characteristically found in M4/M5 age to a 15 cM region of 21q22.3 has been established. 33 In addition to AML1, this region contains IFNAR, CRF2-4, GART, myelomonocytic subtypes. 35 The breakpoint has recently been molecularly defined 36 and found to be rooted at chromoand SON. containing gene with putative acetyltransferase activity, and for the most common translocation with 16p13, in the coding Neurofibromatosis I is a common (approximately 1/3000) autosomal dominant genodermatosis comprised of neurofibsequence of the CREB binding protein.
romas and hyperpigmented café-au-lait skin lesions resulting from mutations in the neurofibromin tumor suppressor gene on chromosome 17q11.2. 57 The encoded protein is in the DNA repair syndromes GAP family and down-regulates the p21-ras proto-oncogene. 58 Individuals with neurofibromatosis 1 are at markedly Autosomal recessive syndromes of DNA repair deficiency are elevated risk for developing CNS and peripheral nerve tumors well known to predispose to malignancy, especially hematothat include gliomas, schwannomas, and neurofibrosarcomas, logic neoplasms.
as well as rhabdomyosarcomas of skeletal muscle. 59 Although less frequent, there is an estimated 221-fold increased risk for juvenile CML, usually with associated monosomy 7, and a five-fold increased risk for ALL and a 10-fold increased risk Bloom syndrome:
Bloom syndrome features growth retarfor non-Hodgkin lymphoma. 60 Myelodysplasia, occasionally dation, characteristic facies, photosensitive telangiectatic eryevolving to AML, occurs disproportionately commonly among thema, café-au-lait skin pigmentation, and immunodeficiency patients. 61 There seems to be an association between leukewith recurrent infections 37 and is most common in the Ashmia in neurofibromatosis I and the additional skin finding of kenazi Jewish population. 38 AML, ALL, lymphoma, and other xanthogranuloma. 62 Loss of heterozygosity with deletion of malignancy occur in about 25% of patients. Cells from affecthe normal allele has been demonstrated in malignant ted individuals demonstrate an increased frequency of sister myeloid-derived clones from children with neurofibromatosis chromatid exchanges, 39 and the responsible gene on 15q26.1 I. 63 Epidemiological evidence suggests that myeloproliferative has been identified as a putative DNA helicase, 40 related to disease occurs more commonly in boys with neurofibro-E. coli RecQ. matosis I and is more frequently associated with maternal inheritance.
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Ataxia telangiectasia: Ataxia telangiectasia is characterized by progressive cerebellar ataxia, telangiectatic skin Li-Fraumeni syndrome lesions, and recurrent sinopulmonary infections consequent to the combination of neurologic depression and mild immunoLi-Fraumeni syndrome is the consequence of autosomal deficiency. 41, 42 About 15-20% of patients develop maligdominantly inherited germline mutation of the p53 tumor supnancy, usually by age 15 years, and most are of lymphoid pressor gene on chromosome 17p13.1. 65 Affected individuals origin, including Hodgkin and non-Hodgkin lymphoma, and are predisposed to the development of multiple types of T cell ALL. 43, 44 The cellular defect is characterized by a failure tumors, most especially sarcomas of muscle, bone, and soft to inhibit DNA synthesis following radiation and disobedience tissue, as well as brain tumors, melanoma, breast cancer, to the G1-S transition checkpoint of the cell cycle. 45 The culbronchogenic lung cancer, melanoma, and prostate and panprit gene on 11q22-q23 encodes ATM, a putative phosphatidcreatic carcinoma. Although leukemia and lymphoma occur ylinositol kinase homologous to yeast proteins involved in in the Li-Fraumeni syndrome, they are somewhat less frequent meiotic recombination and cell cycle control. 46 Two variants than the other tumor types.
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of ataxia telangiectasia, Nijmegen breakage syndrome and Berlin breakage syndrome, have similar cellular, immunological, and chromosomal findings, but differ clinically by the Immunodeficiency syndromes presence of microcephaly and a characteristic birdlike facies. 47 The gene for these disorders was recently mapped to The X-linked recessive Wiskott-Aldrich syndrome is characchromosome 8q21. 48 terized by eczema, thrombocytopenia with small platelets, immunodeficiency, and bloody diarrhea. 44 The responsible gene encodes a proline-rich protein on Xp11.23-p11.22.
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Death usually occurs before age 10 years from a combination Fanconi anemia:
Fanconi anemia consists of pancytopenia with variable congenital abnormalities including short of infections and recurrent hemorrhage, although patients are also susceptible to malignancy, particularly B cell lymstature and skeletal dysplasia with hypoplastic thumbs, mental and sexual retardation, skin pigmentary changes, and renal phomas. 68,69 ALL and AML have also been reported. 70 Bruton agammaglobulinemia is an X-linked immunodefianatomic anomaly. 49 The chromosomes of cultured cells from affected individuals are unusually susceptible to breaks ciency disorder characterized by recurrent bacterial infection 71 resulting from failure to produce mature B lymphocytes induced by alkylating and other agents of DNA damage.
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52% of Fanconi anemia patients develop myelodysplasia or and failure of Ig heavy chain rearrangement. The defective gene is Bruton tyrosine kinase 72 mapping to the Xq21.3-q22 AML by age 40. 51 There are at least four cellular complementation groups for Fanconi anemia. 52 Mutations in a gene boundary. There is a 6% risk for development of malignancy, 73 usually of lymphoreticular origin, with a median age FACC on 9q22.3, encoding a cytoplasmic protein of unknown function, have been identified in complementation group C. 53 of onset of 4 years. 74 There also appears to be an increased risk for colorectal carcinoma. 75 Linkage for complementation group A was established to 16q24.3 54 and the gene was recently cloned through a posOther inherited immunodeficiency syndromes, including common variable immunodeficiency, X-linked lymphoproitional strategy 55 and independently by complementation of cellular phenotype. 56 The protein product is predicted to conliferative syndrome, and selective IgA deficiency are associated with non-Hodgkin lymphoma. 76 In considering leukemia tain a leucine zipper and nuclear localization signals.
and malignancy associated with genetically determined nificant antecedent myelodysplastic illness), or families with combinations of myelodysplasia and AML have all been immunodeficiency syndromes, two possibilities need to be distinguished, namely (1) that the leukemia is directly related reported. There is one family with just myelodysplasia.
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There are at least another four in which individuals developed to the underlying genetic defect; or (2) that the leukemia is a consequence of the immunodeficiency and that the precise either AML or myelodysplasia with or without progression to AML (Refs 13, 94, 95, and a family I have consulted upon). nature of the genetic defect is irrelevant. Support for the latter possibility comes from the observations of increased maligThere are 16 families in which individuals developed nearly exclusively AML, without evidence of protracted myelodysnancy, frequently hematopoietic, among acquired immunodeficiencies, including AIDS, autoimmune disease, chemoplasia (Refs 96-108, pedigree Nos 18 and 21 of Ref. 109, and an additional family that I have cared for). therapy-and radiotherapy-associated immunodeficiency, and transplant-related immunosuppression. 76 Many of the individuals in these families were reported before the current era of FAB classification and molecular refinement of diagnosis; it is therefore difficult to establish subtype. In those families in which modern criteria have been
Other syndromes applied to AML subtyping, it appears that multiple, different AML subtypes occur within the same family, as for example, The Shwachman-Bodian syndrome of autosomal recessive pancreatic insufficiency with congenital pancreatic lipomadocumented in Ref. 94 . Presumably, the defective gene acts early in the course of hematopoietic differentiation, and the tosis and moderate dwarfism has bone marrow abnormalities similar to Fanconi anemia in that there is early onset pancytoparticular subtype is determined by the spectrum of secondary mutagenic events in genes acting later in the sequence of penia with a similar distribution of hematologic malignancy 77 but also an increased risk for pediatric myelodysplasia.
13 A hematopoietic differentiation. Two exceptions to this are found in families with monocytic (FAB M5) or erythroleudifferentiating feature is that there appears to be an absence of chromosomal fragility. 78 A t(6;12)(q16.2;q21.2) chromosomal kemic subtypes (M6). Two families have been reported in which three individuals presented identically with monocytic translocation observed in one patient may suggest a causative locus. 79 AML. 100, 110 (The second of these families 110 differs in that all the affected are siblings within a single generation and the Autosomal recessive Kostmann's infantile genetic agranulocytosis usually terminates with death from AML by the age of onset is in infancy. Such a pattern is consistent with autosomal recessive transmission, or autosomal dominant inheritance 3. 80 Many of the affected individuals come from Norrbotten county in northern Sweden, where the gene was probably with anticipation, see below.) Four families 105, 106, 108, 111 and a fifth that I have cared for, have been reported with individuals introduced through a founder effect. 81 In several non-Swedish patients mutations in the GCSF receptor on chromosome presenting with a unique myelodysplasia involving erythropoietic precursors frequently culminating in acute erythroleuke1p35-p34.3 have been identified. 82 The Blackfan-Diamond syndrome of congenital hypoplastic mia. The term 'erythremic myelosis' or DiGuglielmo syndrome has been used to describe the characteristic anemia and growth retardation with characteristic facies has also been associated with AML. 83 Both autosomal dominant myelodysplasia. Presumably, the aberrant genes in these families are limited to initiating leukemia only in restricted suband autosomal recessive forms are known.
types of myeloid lineages. The proband in the erythroleukemia family that I evaluated was positive for mitomycin and diepoxybutane induced chromosome fragility, suggesting that Pure familial leukemia familial DiGuglielmo syndrome could be related to, or a variant of, Fanconi anemia. Chromosome fragility testing has Non-syndromic leukemia can be classified on the basis of its inheritance pattern and by the spectrum of the involved hemaapparently not been performed on the other erythroleukemia families. topoietic lineages (Table 1) .
Autosomal dominant chronic lymphocytic leukemia Autosomal recessive childhood myelodysplasia with (CLL) monosomy 7
Epidemiological evidence suggests that CLL may have the strongest hereditary component of all the leukemias. In some At least nine families have been reported in which multiple siblings have developed myelodysplasia, often progressing to surveys, up to a third of patients with CLL have at least one first degree relative with hematologic malignancy. 2,112 Never-AML. [84] [85] [86] [87] [88] [89] [90] [91] The constant features in these families are a childhood onset and the presence of bone marrow monosomy for theless, reports of familial CLL are uncommon, and few pedigrees are known. Seven families are multigenerational, conchromosome 7. The consistent absence of cases in other generations is compatible with autosomal recessive inheritance. (1) the selection of parents with late disease onset due to limitation of reproductive success in those affecconsistent with autosomal dominant inheritance. The small size and number of such pedigrees, however, makes it possted early in life; (2) selection of offspring with early onset due to rarity or severity increasing medical attention; and ible that these represent chance clusterings without a heritable component. In a large study of 382 offspring of survivors of (3) selection of cases with simultaneous onset in parent and child, resulting in increased reporting. His conclusions were childhood leukemia (usually ALL) and non-Hodgkin lymphoma, 123 no increased risk of malignancy was observed, suglargely considered as authoritative on the subject until quite recently, when it was definitively shown to the contrary that gesting that the heritable component of, at least ALL, may be small or non-existent. Reports of three families with multiple anticipation is a reality in at least Huntington disease, myotonic dystrophy, and some other inherited neurological affected children within a sibship (Refs 124 and 125, and in the cosanginuous family of Refs 126 and 127) are unlikely to diseases, whose molecular mechanism results from the intergenerational expansion of unstable trinucleotide repeat represent sporadic clustering and are consistent with autosomal recessive inheritance.
sequences (reviewed in Ref. 147 ). My group first considered the possibility that anticipation was operative in autosomal dominant leukemia after observing a drop in age from one generation to the next in the family Familial chronic myelocytic leukemia (CML) that we first reported. 94 We were also intrigued by the possible coincidence of ataxia and leukemia in this and a second famThere are four families with multigenerational CML (Refs 128 and 129 and pedigree Nos. 28 and 59 of Ref. 109), consistent ily 89 as well as the co-existence of myeloproliferative disease and Huntington disease in a third family. 142 Since CAG trinuwith autosomal dominant inheritance.
cleotide repeats encoding polyglutamine are a motif common to some transcriptional activator genes, 148 which could conceivably be attractive candidate leukemia genes, we were Autosomal dominant inheritance of multiple leukemia types motivated to test this hypothesis. We reviewed all of the reports of familial leukemia that we could identify and that also met select criteria likely to exclude families with appreciTwenty-four families have been reported with multiple individuals developing different or unspecified types of leukemia able ascertainment bias. 20 The pedigrees were aligned by generation, and age-dependent penetrance curves were con- of onset is 57 years in the grandparental generation, 32 years in the parental generation, and 13 years in the youngest genermed of). In some families there is co-segregation of acute and chronic myeloid leukemia, while in other families there are ation. We also analyzed the age of onset in affected parentchild pairs in these families and found a mean intergenermixtures of myeloid and lymphoid leukemias.
ational age decline of 28 years in the 21 affected parent-child pairs. Of 18 affected individuals from seven families transmitting CLL, age-dependent penetrance curve analysis is shown X-linked recessive leukemia (Figure 2) , and the mean age of onset in the parental generation is 66 years and in the youngest generation is 51 years. There is one family in which seven males were affected with differing subtypes of leukemia, and X-linked recessive inherit-(Most of the pedigrees with CLL consisted of just two generations.) Of nine parent-child pairs with CLL, the mean ance has been proposed. 138 This pattern of inheritance could also be explained through autosomal dominance and anticipation (see below).
Other hematopoietic malignancy
A smattering of families with familial myeloproliferative disease (Refs 139-142 and references contained therein), generally stopping short of CML, and lymphoma 143, 144 have been reported. Autosomal dominant inheritance (with anticipation, see below) appears to be the mode of genetic transmission for these illnesses, as well.
Anticipation in familial leukemia
Anticipation is the observation of increasing severity or earlier age of onset of disease occurring with each passing generation for an autosomal dominant disorder. It was first reported early in the century for Huntington disease and myotonic dystrophy
Figure 1
Age-dependent penetrance of familial AML by generation.
(reviewed in Ref. 145 ) and was widely regarded as a true inherited neurodegenerative disease. Should this prove true, then there are unique implications for the genesis of leukemia in the more common, non-inherited cases. The CAG/CTG repeats of Huntington disease, myotonic dystrophy, and the spinal cerebellar ataxias, in addition to demonstrating intergenerational meiotic instability, also exhibit mitotic instability. 156 Replicative instability of repetitive DNA sequences is a phenotypic feature of many solid tumors, such as spontaneous and hereditary nonpolyposis colorectal carcinoma, and results from abnormalities in DNA repair. 157 Somatic expansion of an unstable repeat sequence in one such gene could be the initiating event in leukemia. Supportive observations come from the findings that subsets of leukemia demonstrate both microsatellite 158-160 and trinucleotide repeat instability. 161 A speculative model for leukemia initiation incorporating pure familial leukemia, familial leukemic syndromes, and sporadic cases is advanced in Figure 3 . I postulate that there
Figure 2
Age-dependent penetrance of familial CLL by generation.
are a set of leukemia genes. These genes, limited in number to the few different clinical phenotypes of familial leukemia syndromes, would have an unstable repetitive DNA sequence age of intergenerational decline is 21 years. For both AML and CLL the results are highly statistically significant and robust in tract. In the germline of individuals from the rare autosomal dominant pure leukemia families, this tract has expanded in the face of rigorous tests to exclude ascertainment bias. Inspection of the rare pedigrees transmitting other types of leulength. Expansion beyond some critical length both confers the phenotype (either through inactivation, as is the case with kemia also appear consistent with anticipation with similar intergenerational age drops in virtually every parent-child CGG repeat expansion in Fragile X syndrome, or through toxic gain-of-function, as is the case with CAG repeat expansion pair. While sampling biases can never be completely excluded, anticipation appears evident in each of the multiin Huntington disease 147 ) and also results in vulnerability to continued expansion during meiosis (thus accounting for generational leukemia families that I review here.
Remarkably confirmatory evidence for anticipation in famanticipation). Rarely, repetitive tracts of normal length in normal individuals could spontaneously expand either during ilial leukemia can be drawn from earlier studies. Videbaek 109,149 observed anticipation in his exhaustive review of meiosis or mitosis. If the de novo expansion occurred during meiosis in the formation of gametes, this may give rise to all cases of familial leukemia prior to 1947. Collectively analyzing pedigrees with all forms of familial leukemia, he found childhood onset leukemia, such as ALL, in the offspring of normal individuals. It is conceivable that parental exposure to an average age of onset in parents at 57.0 years, children at 33.8 years, and grandchildren at 11.7 years.
109,150 Sampling DNA damaging agents could predispose to de novo expansions. Alternatively, the de novo expansion could occur bias again seems unlikely, because a similar intergenerational drop in age was found between affected uncle-aunt and mitotically in the somatic tissue of the bone marrow or lymph nodes. Since the likelihood of significant somatic expansion nephew-niece pairs, but was not seen when comparing the age of onset between the oldest and youngest individuals should be proportional to the total number of mitotic events, it would be expected that such events would become increaswithin large sibships. In a population-based survey that considered familial relationships in all forms of hematopoietic ingly probable with advancing age, such as in CLL and AML, where the incidence increases in the elderly, or following malignancy, including leukemia, lymphoma, and myeloma, the mean difference between ages at death in affected parentexposure to carcinogens. In the case of DNA repair deficiency, such as with Bloom syndrome, the underlying child pairs was 38 years. 130 Further evidence for anticipation is found in a peculiar inherited defect could predispose to repeat expansion. Alternatively, the mitotic expansion could result from the stepwise inheritance pattern seen in seven pedigrees in which parallel sibships related as first cousins are affected with leukemia malignant progression involving other known proto-oncogenes and tumor suppressor genes. The nature of the postulated repetitive sequences is uncertain, but trinucleotide repeats should at least be considered, or autosomal dominant inheritance. The most plausible explanation is to suppose that there is autosomal dominant inheritbecause they are so far the only known sequences that have been associated with anticipation. A significant observation is ance with anticipation and that the parental generation (where all the individuals are related as siblings) has a reduced penthat leukemia is the type of malignancy that overwhelmingly results from exposure to radiation or alkylating agents used in etrance because of a requirement for a greater age of onset in this generation.
chemotherapy. 7 It might thus be supposed that the repetitive sequences in these postulated leukemia genes should be uniquely vulnerable to the spectrum of DNA damage induced by these events.
A model for leukemia initiation based on trinucleotide repeat expansion
The molecular mechanism of anticipation in leukemia is Candidate leukemia genes containing unstable repeats unknown. It is possible that anticipation in leukemia results from expansion of an unstable repetitive sequence in analogy A number of genes are known to contain repetitive sequence motifs, particularly trinucleotide repeats, and many of these to the situation with trinucleotide repeat expansion in
Figure 3
Model for leukemia initiation based on DNA repeat expansion.
sequences are polymorphic in the population. For some of kemia has been reported in the mother of at least one patient with the Jacobsen syndrome 169 (who, although reported some these genes circumstantial arguments for a role in neoplasia have been advanced (reviewed in Ref. 162 ). There is some years ago and not molecularly tested, would presumably have CCG repeat expansion in CBL2). CBL2 was first cloned as the limited evidence potentially implicating these loci as leukemia genes.
B cell lymphoma-inducing oncogene of a murine retrovirus. It contains a RING finger zinc-binding motif, multiple consensus bindings sites for SH3 domains, and may modify receptor tyrosine kinase-mediated signal transduction.
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AF9
Additional evidence implicating the distal long arm of chromosome 11 in the initiation of leukemia is that it is the site of In the AML family that my group first reported, 94 at least two affected individuals co-inherited a constitutional cytogenetfrequent chromosomal abnormality in secondary, treatmentrelated AML, 171 as well as being the locus for the ATM and ically visible banding variation on the proximal region of the short arm of chromosome 9p22. This provides some weak evi-HRX trithorax genes. It is conceivable that genetic instability in the vicinity of CBL2 leads to larger abnormalities of 11q. dence for linkage to this region. One attractive candidate gene in this region is AF9, which is the frequent site of reciprocal translocation with the HRX trithorax gene on chromosome 11 in recurrent t(9p22;11q23) associated with AML. 163 The gene is a homologue of ELL 164 which functions as an RNA poly-BCR merase processivity factor. Another RNA polymerase processivity factor is encoded by the VHL locus (reviewed in Ref.
There is a polymorphic CGG repeat in the first exon of the 165), which is well-established to be a tumor suppressor gene, BCR gene on chromosome 22q11, which when translocated causative of the Von Hippel-Lindau syndrome of cerebroretiwith the ABL oncogene on chromosome 9q34 forms the Philanal hamartomas and renal cell carcinoma. Interestingly, AF9 delphia chromosome characteristic of 90% of CML, 10% of has a large CAG repeat encoding a polyserine tract that is ALL, and 5% of AML patients. 172 The length of the repeat has polymorphic in the population. 166 not been found to differ, however, in patients with Philadelphia chromosome positive leukemias. 173 
CBL2
Another of the recognized trinucleotide repeat diseases is the 21q22 locus Jacobsen syndrome. In this disease there is expansion of a CCG repeat on chromosome 11q23.3 in the CBL2 protooncogene. 167 Individuals with expansion of this sequence are As mentioned, in a large family inheriting platelet granule defects and a predisposition toward myeloid leukemia, linkat risk for chromosome breakage with consequent terminal deletion of the distal long arm of chromosome 11 during age to chromosome 21q22.1-22.2 has been determined. 33 From the published clinical descriptions of this family there is gamete formation. Offspring inheriting this chromosomal abnormality are affected, although the phenotype is described inadequate data to comment on the presence or absence of anticipation nor on the magnitude of risk for leukemia. Two as rather mild in comparison to other congenital chromosomal abnormalities and consists of subtle facial dysmorphism and other families (Ref. 131 , and one I have consulted upon) with a similar phenotype, however, do have some evidence of variable mild to moderate mental retardation. There is some evidence for CBL2 mutation in sporadic leukemia, 168 and leuanticipation.
16q22 fragile site and satellite repeat instability in DNA repair. 192 Although the role of the BRCA genes remains controversial, 191 the most recent data suggest it to be involved in maintaining chromosomal fidelity during A distinguishing feature of anticipation in familial leukemia is an absence of parental sex effect. In contrast, in Huntington mitosis. 193 Before the discovery of these genes, it was proposed that a mutation in a DNA repair gene could be an initidisease trinucleotide repeat expansion occurs preferentially through paternal meiosis while in myotonic dystrophy and ating step in carcinogenesis, as it would invoke a cascade of mutations in downstream tumor suppressor and proto-oncofragile X syndrome expansion occurs preferentially in female meiosis. It is therefore possible that a different sequence repeat genes. [194] [195] [196] The discovery of a 'mutator phenotype' in hereditary nonpolyposis colorectal carcinoma and other sporadic or even a different molecular mechanism is responsible for anticipation in leukemia. In fact, a different sort of repetitive malignancies 197 seems to prove these predictions. A speculative hypothesis accounting for anticipation in familial maligsequence vulnerable to intergenerational instability is repetitive 'satellite' DNA. 174 Variations in satellite repeat length nancy is that the secondary mutations that result from such genomic infidelity may not be just somatic, but could conceivhave been associated with cancer risk at HRAS 175 and ovarian cancer risk in BRCA1 families. 176 ably occur in the germline and be transmitted to children (Figure 4) . If it were indeed the case that the familial leukemia Evidence that microsatellite repeat instabilities could lead to leukemia comes from a report of a family with leukemia genes are involved in the maintenance of genomic integrity, then a child's risk of leukemia may not result only from the transmitting a chromosome 16q22 folate-sensitive fragile site. 177 In this family, a 69-year-old man presented with simulinheritance of a single defective gene, but could in addition require the inheritance of multiple de novo germline taneous AML and lymphoma while his 14-year-old daughter presented with ALL. A fragile site in this region has been mutations in downstream genes. In this way, the multistep evolution of leukemia would actually begin in the parental observed in association with sporadic hematopoietic malignancy. 178 This fragile site is likely to be the 16q22 distamycin germline and leukemia would be transmitted not simply through an autosomal dominant pattern but through a poly-A-sensitive FRA16B site that was recently cloned and found to result from amplification of an AT-rich minisatellite repeat. 179 genic inheritance model with a single major ancestral gene and multiple minor genes each resulting from de novo mutation. The unique and variable spectrum of the de novo secondary mutations might account for the clinical variability Gene duplication of leukemia subtypes in multiple family members while the progressive accumulation of mutations across generations The finding of linkage to chromosome 21 in some leukemia/myelodysplasia families is particularly interesting in would account for anticipation. A prediction of this hypothesis is that in a leukemia family, light of the association of Down syndrome with leukemia (and also trisomy 8 mosaicism and leukemia), where it is clear that a parent with the leukemia gene would have a 1/2 probability of having a child who did not inherit the leukemia gene but a gene dosage effect is causative. Instead of expansion of a limited sequence repeat, this raises the possibility that whole who did inherit 1/2 of the cumulative de novo gonadal mutations. It might therefore be expected that there would be gene duplication could be the causative mutation, as has been reported with a polymorphic gene duplication in poly(ADPan increased incidence of congenital abnormalities in leukeribose) polymerase associated with an increased incidence of prostate cancer and multiple myeloma.
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A model for leukemia initiation based on intergenerational inheritance of secondary hits
It should be additionally noted that leukemia is not the only cancer family syndrome for which anticipation occurs. Anticipation has been reported in familial breast cancer 107, [181] [182] [183] [184] [185] and hereditary nonpolyposis colorectal carcinoma. [186] [187] [188] In comparison to leukemia, the data may be more uniquely vulnerable to so-called 'cohort' effects reflecting advancements in diagnostic technology and changes in overall disease incidence. 150, 189, 190 Nevertheless, the data cannot be easily ignored with respect to their implication for anticipation in familial leukemia, and because much of it comes from population registries, it may not be subject to the ascertainment bias issues discussed by Penrose. Two familial breast cancer genes 191 and four hereditary nonpolyposis colorectal carci- hereditary nonpolyposis colorectal carcinoma genes function the possibility that a de novo mutation has occurred, and may 1618-1630. conceivably mean that the first significant 'hit' in the multistep nant course.
